Your browser doesn't support javascript.
loading
Noninferiority of Simplified Dolutegravir Monotherapy Compared to Continued Combination Antiretroviral Therapy That Was Initiated During Primary Human Immunodeficiency Virus Infection: A Randomized, Controlled, Multisite, Open-label, Noninferiority Trial.
Braun, Dominique L; Turk, Teja; Tschumi, Fabian; Grube, Christina; Hampel, Benjamin; Depmeier, Carsten; Schreiber, Peter W; Brugger, Silvio D; Greiner, Michael; Steffens, Daniela; De Torrenté-Bayard, Cornelia; Courlet, Perrine; Neumann, Kathrin; Kuster, Herbert; Flepp, Markus; Bertisch, Barbara; Decosterd, Laurent; Böni, Jürg; Metzner, Karin J; Kouyos, Roger D; Günthard, Huldrych F.
Affiliation
  • Braun DL; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Turk T; Institute of Medical Virology, University of Zurich, Switzerland.
  • Tschumi F; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Grube C; Institute of Medical Virology, University of Zurich, Switzerland.
  • Hampel B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Depmeier C; Institute of Medical Virology, University of Zurich, Switzerland.
  • Schreiber PW; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Brugger SD; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Greiner M; Institute of Medical Virology, University of Zurich, Switzerland.
  • Steffens D; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • De Torrenté-Bayard C; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Courlet P; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Neumann K; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Kuster H; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Flepp M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Bertisch B; Service of Clinical Pharmacology, University Hospital Center, University of Lausanne, Switzerland.
  • Decosterd L; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Böni J; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
  • Metzner KJ; Center of Infectious Diseases Zurich, Switzerland.
  • Kouyos RD; Checkpoint Zurich, Switzerland.
  • Günthard HF; Institute of Global Health, University of Geneva, Switzerland.
Clin Infect Dis ; 69(9): 1489-1497, 2019 10 15.
Article in En | MEDLINE | ID: mdl-30601950

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-Retroviral Agents / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Document type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-Retroviral Agents / Heterocyclic Compounds, 3-Ring Type of study: Clinical_trials / Guideline Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Document type: Article Affiliation country: Switzerland